De Montfort University Leicester (DMU) will play host to the sixth Quality by Design Symposium on Wednesday 21 March.
The event brings together academics, regulators and experts from the pharmaceutical industry to share the latest research and implementation of Quality by Design (QbD), which is a scientific approach for the development and manufacture of medicines and healthcare products.
The symposium will be organised by the Leicester School of Pharmacy and will be held at The Venue@DMU. This year it will focus on ‘Medicines Manufacture: Road Map to Innovation’.
The programme will cover the latest Quality by Design news from academia, the use of innovation and technology, success stories and examples of Quality by Design in practice. It also provides an opportunity for industry professionals to network and learn from senior leaders in the field.
Speakers at the event include experts from major companies such as Pfizer, GlaxoSmithKline and AstraZeneca as well as academics from DMU, University of Cambridge and University of Greenwich.
Dr Walkiria Schlindwein will chair the symposium and said it is a great opportunity for the Leicester School of Pharmacy to host such an important event.
She said: “We are fortunate to be supported by some of the top forward thinking leaders within the Pharma industries. Their contribution to our event has been invaluable.
“This year, the focus is on ‘innovation and technology’ for rapid development and manufacturing of medicines.”
Come to our next open day
DMU graduate has all the right qualities to impress interviewers
Pharmacy students help improve health of Leicester’s homeless population
DMU teaches Quality by Design in its pharmaceutical courses and Dr Schlindwein believes that this event reflects the university’s commitment to the process.
She added: “The Leicester School of Pharmacy is very committed to QbD applied to both its teaching and research activities.
“We are proud to be part of this unique collaboration between academia and industry, which we see as a long term partnership. The event will highlight a range of strategies to establish and raise the profile of QBD to the wider pharmaceutical industry.”
Posted on Tuesday 6th March 2018